Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

182
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
182
Long-term Depression01:05

Long-term Depression

31.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.9K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

236
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
236
Depression: Overview01:18

Depression: Overview

424
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
424
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

425
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
425
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

334
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in leukocytes and CRP in different treatments of major depression.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled <i>changePDD</i> trial.

BMJ open·2026
Same author

Differential DNA-methylation of synaptic genes in CSF and blood in schizophrenia.

Schizophrenia (Heidelberg, Germany)·2026
Same author

A randomized controlled trial of an interactive digital therapeutic for stress and burnout management.

Npj mental health research·2025
Same author

Decision tree-based approach to robust Parkinson's disease subtyping using clinical data of the Michael J. Fox Foundation LRRK2 cross-sectional study.

Frontiers in artificial intelligence·2025
Same author

Epigenetic alterations of serotonergic but not dopaminergic signalling in compulsive sexual behaviour disorder.

Behavioural brain research·2025

Related Experiment Video

Updated: Oct 12, 2025

Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
09:14

Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging

Published on: March 14, 2025

420

OXTR-Related Markers in Clinical Depression: a Longitudinal Case-Control Psychotherapy Study.

Iris C Reiner1,2, Gerald Gimpl3, Manfred E Beutel4

  • 1Department of Psychosomatic Medicine and Psychotherapy, University Medical Center, Untere Zahlbacher Str. 8, 55131, Mainz, Germany. iris.reiner@unimedizin-mainz.de.

Journal of Molecular Neuroscience : MN
|November 25, 2021
PubMed
Summary

Depressed patients showed altered urinary oxytocin and OXTR DNA methylation, differing between those who remitted and those who did not after psychotherapy. These biomarkers may predict treatment outcomes.

Keywords:
DepressionOXTR methylationOxytocinPsychotherapy

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

868
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.6K

Related Experiment Videos

Last Updated: Oct 12, 2025

Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
09:14

Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging

Published on: March 14, 2025

420
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

868
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.6K

Area of Science:

  • Neurobiology
  • Psychiatry
  • Genetics

Background:

  • Oxytocin and its receptor (OXTR) gene methylation are implicated in mood disorders.
  • Understanding their stability and response to psychotherapy is crucial for depression treatment.

Purpose of the Study:

  • To investigate changes in plasma/urinary oxytocin and OXTR DNA methylation during inpatient psychotherapy.
  • To differentiate these biomarkers between depression remitters and non-remitters.

Main Methods:

  • Blood and urine samples from 43 depressed patients and 42 controls were analyzed at baseline and discharge.
  • Serum/urine oxytocin measured by ELISA; OXTR DNA methylation assessed via bisulfite sequencing.
  • Analysis differentiated between patients who remitted and those who did not.

Main Results:

  • Plasma oxytocin levels were stable and unaffected by depression or psychotherapy.
  • Non-remitting patients had lower urinary oxytocin levels pre- and post-treatment.
  • Lower exon 1 OXTR methylation and higher exon 2 OXTR methylation were observed in remitters compared to non-remitters.

Conclusions:

  • Urinary oxytocin and OXTR DNA methylation patterns are relatively stable but differ significantly between remitting and non-remitting depressed patients.
  • These OXTR-related markers may serve as predictors for inpatient psychotherapy outcomes in depression.
  • Further research is needed to validate these findings.